Over the past five years, the cosmetic industry has met with several legislative changes. Within the new legislative package, including the new REACH and CLP, it is important to find a comfortable routine that will minimize costs while staying effective and compliant with all regulations.
Creating & Leading Patient Experience Excellence
Read the full interview with Dr. Ahmed Mohammad Abu-Abah, CEO at King Abdullah BinAbdulaziz University Hospital and gain insight into the creating & leading patient experience excellence.
Dr. Ahmed Mohammad Abu-Abah
King Abdullah Bin Abdulaziz Hospital
What is your patient experience plan for 2017? What will you do differently?
We will focus on three main domains: improving the patient-driven culture by innovative ideas, investing more on improving the patient experience by collaborating with leading institutions in this field, then being accredited in patient experience. Here are more details about this plan.
1. Internal innovative projects aiming to improve patient driven culture like:
- Inpatients and outpatients, patient experience rounds
- CEO patient experience rounds
- Patient experience awareness of the staff.
- Smile: a project to improve communication between healthcare providers and patients
- Thank you: another project as a way of using health care appreciation to improve mutual respect
2. Cleveland Clinic Collaboration: This collaboration will focus on the following aspects:
- On-site Visit and Observation
- Knowledge Sharing and Transfer
This collaboration may also include patient experience on-site assessment and future participation in a patient experience leadership forum.
3. Planetree Designation Accreditation: The Planetree Person-Centered Care Designation represents the highest level of achievement in patient-centered care based on evidence and standards. The program provides a structured, operational framework for evaluating the organizational systems and processes necessary to sustain organizational culture change. Through a set of experience-based and evidence-based criteria, the program converts the aspirational aim of becoming more “patient-centered” into something that is defined, attainable and measurable.
What are the most common pitfalls among organizations when pursuing / trying to improve patient experience?
The most common pitfalls are:1. Implementing the culture
2. Understanding the patient experience department and the staff’s role
3. Engaging the healthcare providers, especially physicians
4. Familiarizing the patient with their rights and responsibilities
5. Shortage of qualified staff trained in patient experience
How do you impact culture to develop your people around these concepts?
There’s no doubt that developing patient driven culture is a cornerstone in implementing a successful program; however, it is very difficult. These are some of the ideas that we implement in order to impact the culture:
1. Patient experience is part of our strategy and all the executive departments should have initiatives that improve patient experience.
2. Patient experience awareness programs which involve healthcare providers and patients
3. Engaging the healthcare provider to improve patient-centered care.
4. Teaching the patients their rights and responsibilities.
5. Implementing innovative ideas like executive rounds, the Smile program, the Thank you program and others.
How has technology supported the pursuit of patient experience excellence?
Technology has an important role in the implementation of patient experience in KAAUH. An important tool that is implemented through technology is communication. Technology has made communication more convenient by creating easy ways to communicate. We implement a 100% electronic filing system that provides confident storage and access to files for patients and allows healthcare providers to know what they need to know about the patient, so they can provide the best care. In our OPD, we have a fully automated system which starts with an electronic check-in (by fingerprint) and ends when the patient gets out with all the services he needed, wrapped up with an SMS message asking the patient to evaluate the services provided to him. We are about to launch our patient portal, where the patient will be able to access his EMR and get whatever information he needs in a timely and easy fashion.
For more information about the 1st GCC Patient Experience Summit, please write to firstname.lastname@example.org or visit the link below:
Interested in this topic?
Advanced Protein Aggregation & Characterization
This training will focus on occurrence of particles in drug products, effects of protein aggregates, critical process and parameters. Attendees will gain overview of on utility and limits of predictive experiments, learn concerns from the authorities and relevant aggregation guidelines, and more.
CMC Analytical Comparability: Methods & Strategies for Biologics, Biosimilars & Biobetters
Attendees will be introduced to comparability in biosimilar development, the analytical strategies of protein characterization of biosimilars, the structure of proteins, in vitro pharmacology and much more.
Corporate Compliance & Transparency in the Pharmaceutical Industry
This two-day conference will serve as a platform for an open and dynamic dialogue with HCPs and patients to achieve common goals. Learn how to embed compliance in the business and develop one simple system for managing compliance & transparency in a complex and regulated environment.
Driving the national agenda of Medical tourism through PX Excellence
Read the interview with Dr. Layla Al-Marzouqi, Director of Medical Tourism Council at Dubai Health Authority, and learn how to enrich patient experience and quality of healthcare.
No more trouble with dangerous good shipments
Global temperature controlled pharmaceutical shipments are constantly faced with new logistics challenges and regulations. This January 2017, IATA Dangerous Goods Regulations added further complexity to shipping cold chain products compliantly.
5 Changes in Signal Detection Management
The European Medicines Agency, regulatory authorities in the Member States and marketing authorisation holders are responsible for detecting and managing safety signals. A safety signal is generally defined as information about a new or known Adverse Event that may have been caused by a medicine, where it is therefore necessary to conduct further investigation. Evaluation of safety signals plays a major role within pharmacovigilance. Therefore, it is vital for regulatory authorities to know the latest updates detailing the risks and benefits of medicines. The EudraVigilance database is an important source of information on suspected adverse reactions and signals.